Metraipolis › archive › dc_25eb92b8eae2

Development of a bispecific antibody that inhibits EGFR and B7H3 in NSCLC — Europe PMC PMID:41291854

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41291854
DOI
10.1186/s40364-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-08T07:06:29.956Z
SHA-256 of the archived text
c8c8659215035fbf6c0ac05f7bb3bfeeaccf0328ede1a78dd7ce17f458da68fb
Stable URL of this page
https://metraipolis.com/documento/dc_25eb92b8eae2

How to cite

Development of a bispecific antibody that inhibits EGFR and B7H3 in NSCLC — Europe PMC PMID:41291854 — Europe PMC (en), https://europepmc.org/article/MED/41291854 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_25eb92b8eae2 (Metraipolis archive dc_25eb92b8eae2, sha256 c8c8659215035fbf6c0ac05f7bb3bfeeaccf0328ede1a78dd7ce17f458da68fb)
BibTeX
@misc{dc25eb92b8eae2,
  title = {Development of a bispecific antibody that inhibits EGFR and B7H3 in NSCLC — Europe PMC PMID:41291854},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41291854},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_25eb92b8eae2; sha256 c8c8659215035fbf6c0ac05f7bb3bfeeaccf0328ede1a78dd7ce17f458da68fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41291854. Agents can read the archived copy with the MCP tool read_document.